DPPC-d9

• CAT Number: S000120
• Molecular Formula: C40H71D9NO8P
• Molecular Weight: 743.09
• Purity: ≥95%
• Target: Endogenous Metabolite
• IUPAC Name: [(2R)-2-hexadecanoyloxy-3-(13,13,14,14,15,15,16,16,16-nonadeuteriohexadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate
• InChI: InChI=1S/C40H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-39(42)46-36-38(37-48-50(44,45)47-35-34-41(3,4)5)49-40(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3/t38-/m1/s1/i1D3,6D2,8D2,10D2
• InChIKey: KILNVBDSWZSGLL-WLMBCDKQSA-N
• SMILES: [2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])CCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC

DPPC-d9, a premium pharmaceutical research compound designed for advanced studies in lipidomics and pulmonary research. As a deuterated analog of Dipalmitoylphosphatidylcholine (DPPC), it offers enhanced stability and improved tracing capabilities. DPPC-d9 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for respiratory diseases and in the study of lipid metabolism. Trusted by leading laboratories, DPPC-d9 is your go-to solution for cutting-edge lipidomics and pulmonary research. Unlock new possibilities in lipid and respiratory health with DPPC-d9, where innovation meets reliability.